These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18992264)

  • 21. Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.
    Ahlborn LB; Dandanell M; Steffensen AY; Jønson L; Nielsen FC; Hansen TV
    Breast Cancer Res Treat; 2015 Apr; 150(2):289-98. PubMed ID: 25724305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of common BRCA1 and BRCA2 variants.
    Deffenbaugh AM; Frank TS; Hoffman M; Cannon-Albright L; Neuhausen SL
    Genet Test; 2002; 6(2):119-21. PubMed ID: 12215251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.
    Hamann U; Liu X; Bungardt N; Ulmer HU; Bastert G; Sinn HP
    Eur J Hum Genet; 2003 Jun; 11(6):464-7. PubMed ID: 12774040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.
    Carvalho RS; Abreu RB; Velkova A; Marsillac S; Rodarte RS; Suarez-Kurtz G; Iversen ES; Monteiro AN; Carvalho MA
    PLoS One; 2014; 9(5):e97766. PubMed ID: 24845084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
    Fernandes VC; Golubeva VA; Di Pietro G; Shields C; Amankwah K; Nepomuceno TC; de Gregoriis G; Abreu RBV; Harro C; Gomes TT; Silva RF; Suarez-Kurtz G; Couch FJ; Iversen ES; Monteiro ANA; Carvalho MA
    J Biol Chem; 2019 Apr; 294(15):5980-5992. PubMed ID: 30765603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.
    Starita LM; Islam MM; Banerjee T; Adamovich AI; Gullingsrud J; Fields S; Shendure J; Parvin JD
    Am J Hum Genet; 2018 Oct; 103(4):498-508. PubMed ID: 30219179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling.
    Moghadasi S; Hofland N; Wouts JN; Hogervorst FB; Wijnen JT; Vreeswijk MP; van Asperen CJ
    J Med Genet; 2013 Feb; 50(2):74-9. PubMed ID: 23231788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat.
    Cortesi L; De Nicolo A; Medici V; Marino M; Turchetti D; Pradella LM; Rossi G; Parisini E; Federico M
    Breast Cancer Res Treat; 2012 Jul; 134(1):435-41. PubMed ID: 22527099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
    Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
    Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
    Gaildrat P; Krieger S; Théry JC; Killian A; Rousselin A; Berthet P; Frébourg T; Hardouin A; Martins A; Tosi M
    J Med Genet; 2010 Jun; 47(6):398-403. PubMed ID: 20522429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional impact of missense variants in BRCA1 predicted by supervised learning.
    Karchin R; Monteiro AN; Tavtigian SV; Carvalho MA; Sali A
    PLoS Comput Biol; 2007 Feb; 3(2):e26. PubMed ID: 17305420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombination-based method to characterize human BRCA1 missense variants.
    Guidugli L; Rugani C; Lombardi G; Aretini P; Galli A; Caligo MA
    Breast Cancer Res Treat; 2011 Jan; 125(1):265-72. PubMed ID: 20737206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
    Puget N; Torchard D; Serova-Sinilnikova OM; Lynch HT; Feunteun J; Lenoir GM; Mazoyer S
    Cancer Res; 1997 Mar; 57(5):828-31. PubMed ID: 9041180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
    Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
    J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accurate classification of BRCA1 variants with saturation genome editing.
    Findlay GM; Daza RM; Martin B; Zhang MD; Leith AP; Gasperini M; Janizek JD; Huang X; Starita LM; Shendure J
    Nature; 2018 Oct; 562(7726):217-222. PubMed ID: 30209399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.